Sylvia J. Young
LINCOLN EDUCATIONAL SERVICESAbout Sylvia J. Young
Independent director of Lincoln Educational Services Corporation since 2023; age 63 as of March 20, 2025. Veteran hospital executive: former President & CEO of HCA Continental Division (2012–2023), previously President of HCA’s Sunrise Health System; currently CEO of Young Consulting Advisors, LLC. Education: B.A. in Public Administration (Samford University) and Master of Health Administration (University of Alabama at Birmingham). Also serves on the board of Pediatrix Medical Group, Inc. (public) since May 2023 .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| HCA Healthcare – Continental Division | President & CEO of a $3.6B net revenue regional system (HealthONE in Denver, CO; Wesley Healthcare in Wichita, KS) | Jun 2012–2023 | Led division operations; large-scale provider leadership |
| HCA Healthcare – Sunrise Health System | President | Not disclosed (prior to 2012) | Regional health system leadership |
External Roles
| Organization | Role | Tenure | Committees/Notes |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (NYSE: MD) | Director | Since May 2023 | Public company directorship |
| American Hospital Association | At-Large Trustee | Appointed Apr 2019 | National industry governance role |
| Young Consulting Advisors, LLC | CEO | Current | Advisory/consulting leadership |
Board Governance
- Independence: The Board determined all directors except the CEO are independent; Ms. Young is an independent director under NASDAQ rules .
- Committees: Audit Committee member; Compensation Committee member (not Chair). Audit Committee met 4 times in 2024; Compensation Committee met 4 times in 2024 .
- Attendance and engagement: In 2024, the Board met 6 times; each director attended all Board and their committee meetings, except one Nominating & Corporate Governance meeting missed by Mr. Burke; thus Ms. Young had full attendance .
- Skills/expertise (Board’s matrix): CEO/Senior Officer, Industry Experience, Governance/Board Experience, Financial Acumen; Independent .
- Board leadership: Separate Non-Executive Chair; executive sessions of non-employee directors generally with each regular Board meeting .
Fixed Compensation (Director – FY2024)
| Component | Amount (USD) |
|---|---|
| Annual Cash Retainer | $55,000 |
| Audit Committee Member Fee | $4,000 |
| Compensation Committee Member Fee | $6,000 |
| Equity Grant (Restricted Stock – grant date fair value) | $60,000 |
| Total | $125,000 |
- Structure: The standard FY2024 non-employee director package comprised a $55,000 cash retainer, $60,000 in restricted stock (Chair: $105,000), and committee retainers (Audit member: $8,000; Compensation member: $6,000; Committee chairs higher); amounts prorated by service; Ms. Young’s actual line items shown above .
- Grant mechanics: On May 2, 2024, non-employee directors received 5,343 restricted shares each (fair value $60,000) vesting in full on May 2, 2025 (based on $11.23 per share). New directors appointed June 27, 2024 received prorated 4,348 shares (not applicable to Ms. Young) .
Performance Compensation
| Award Type | Grant Date | Shares | Grant-Date Fair Value | Vesting/Performance Terms |
|---|---|---|---|---|
| Time-based Restricted Stock (Director Annual Grant) | May 2, 2024 | 5,343 | $60,000 | Vests 100% on May 2, 2025; no performance metrics |
- Directors do not receive performance-based equity; annual director grants are time-based and vest after one year .
Other Directorships & Interlocks
| Company | Role | Potential Interlock/Conflict Notes |
|---|---|---|
| Pediatrix Medical Group, Inc. | Director (public) | No related-party transactions with LINC disclosed for 2023–2024; company states it engaged in no related person transactions in those years (Juniper-related legacy disclosure noted; none involve Ms. Young) . |
- Related-party oversight: Audit Committee reviews and must pre-approve all related person transactions; none disclosed for 2023–2024 involving Ms. Young .
- Hedging/pledging policy: The Code of Conduct prohibits directors from hedging or pledging company stock (limited exceptions only by Board approval) .
Expertise & Qualifications
- Senior operator with multi-billion-dollar P&L responsibility in healthcare provider systems (HCA Continental Division) .
- Public company governance experience (Pediatrix) and broad board/governance expertise per LINC skills matrix .
- Financial acumen per Board’s skills matrix; Audit Committee service supports financial oversight role .
- Advanced health administration education underpinning sector expertise .
Equity Ownership
| Metric | Amount |
|---|---|
| Total Beneficial Ownership (shares) | 17,440 (includes 12,097 owned + 5,343 unvested RS) |
| Vested Shares | 12,097 |
| Unvested Restricted Shares | 5,343 |
| % of Shares Outstanding | ~0.055% (17,440 / 31,592,807 outstanding as of Mar 20, 2025) |
- Ownership alignment: Annual equity grants and personal holdings create ongoing alignment; company prohibits director hedging/pledging, supporting alignment quality .
Governance Assessment
- Positive indicators:
- Independent director with full 2024 attendance; active on Audit and Compensation Committees, which are fully independent per NASDAQ rules .
- Strong operator background and financial acumen mapped in Board’s skills matrix; relevant for Audit and Compensation oversight .
- Balanced director pay mix in 2024 (~52% cash; ~48% equity by value), with straightforward, time-based vesting; no option grants, minimizing risk of timing concerns .
- No related person transactions involving Ms. Young disclosed for 2023–2024; strong related-party and insider trading controls, including anti-hedging/pledging policy .
- Company say‑on‑pay support of ~93% in 2024 suggests general shareholder satisfaction with compensation governance context .
- Watch items:
- Dual committee workload (Audit and Compensation) increases influence on financial reporting and pay; continued monitoring of committee performance and shareholder feedback recommended .
- RED FLAGS:
- None identified in filings: no attendance issues, no disclosed related-party transactions, no hedging/pledging exceptions, no Section 16(a) delinquencies .